In a sense, quantitative biomedical optics methods seek to enhance and quantify the visual perception of color and brightness of light transmitted through or reflected by biological tissues. This is especially the case for diffuse optical spectroscopy and imaging, which are based on the spectral dependence, spatial distribution, and temporal characteristics of the detected optical signals.
The “color” of tissue is determined by the spectral features of its absorbing and scattering constituents, with hemoglobin playing an important role, given its abundance and the relationship between its oxygen saturation and its absorption spectrum. For example, human skin color is determined by the amount of melanin in the skin, by the hemoglobin in cutaneous circulation, and by other chromophores, such as β-carotene and bilirubin, that may be indicative of pathological conditions. The dilatation or contraction of skin arterioles (for example as a result of warm or cold environments), and the resulting enhancement or reduction in cutaneous blood flow, affects the color of the skin, which, for fair-skinned people, may tend toward white (pallor: vascular constriction), red (erythema: vascular dilatation), or blue/purple (cyanosis: inadequate blood flow). Of note, the blue appearance of superficial veins is due to a combination of the reduced level of venous blood oxygenation, the scattering properties of the skin and blood constituents, and the visual perception of color contrast (Kienle et al., 1996).
The spatial distribution of light transmission through tissue can be affected by an inhomogeneous distribution of chromophores. For example, tumor angiogenesis or hematomas are associated with a focal increase in the concentration of blood in tissue, which results in a localized increase in light absorption.
Temporal characteristics of the detected optical signal may be directly associated with time-varying and dynamic physiological processes (arterial pulsation, respiration-modulated blood pressure, blood flow, etc.), thus yielding potentially valuable diagnostic information, and can also be used to monitor the evolution of metabolic and physiological conditions or drug delivery to tissues.
This chapter describes a representative sampling of in vivo applications of diffuse tissue spectroscopy and imaging, demonstrating how the quantitative methods described in Chapters 10–14 find practical applications in a number of research and clinical areas.